Evidence map›Paper›PMID 42352126›Full record

ArticleEntropy (Basel, Switzerland)2026

DBCL-DFNet: Dual-Branch Contrastive Learning for Multi-Omics Dynamic Fusion.

Yun Dang, Xiaoran Yan, Li Zhou, Dongxi Li

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yun DangCollege of Computer Science and Technology, Taiyuan University of Technology, Taiyuan 030024, China.
Xiaoran YanCollege of Artificial Intelligence, Taiyuan University of Technology, Taiyuan 030024, China.
Li ZhouCollege of Computer Science and Technology, Taiyuan University of Technology, Taiyuan 030024, China.
Dongxi LiCollege of Computer Science and Technology, Taiyuan University of Technology, Taiyuan 030024, China.

Funding

Basic Research Programs of Shanxi Province 202303021211069Key Research and Development Programs of Shanxi Province 202402020101008National Natural Science Foundation of China 32470678
6 · The paper itself

Abstract

Multimodal omics data portray biological processes across molecular layers, yet their heterogeneity and high dimensionality hinder a unified representation. Existing integrative approaches either focus on local feature interactions or adopt static fusion, often overlooking the complementary global sequential context and the dynamic relevance among omics sources. Consequently, clinically critical tasks such as accurate cancer-subtype classification and therapy selection still lack sufficient accuracy and robustness. We introduce the Dual-Branch Contrastive Learning for Multi-Omics Dynamic Fusion Network (DBCL-DFNet), a dual-branch contrastive-learning framework that simultaneously encodes local heterogeneous graphs and global omics sequences, distills key features via contrastive objectives, and employs a dynamic attention mechanism for adaptive, data-driven fusion. Benchmarked on three public cancer multi-omics datasets, DBCL-DFNet outperforms both conventional machine-learning models and state-of-the-art deep-integration methods, establishing a competitive and reliable framework for multi-omics integration and demonstrating potential for precision-oncology decision-making. From an information-theoretic perspective, the framework integrates Copula-entropy-guided feature selection with mutual-information-maximizing contrastive alignment, providing a principled foundation for robust multi-omics integration.

Indexed as

contrastive learningcopula entropyGATheterogeneous graphmambamulti-omics integration

Identifiers

PMID42352126
PMCPMC13298311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.